Angst J, Azorin J-M, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH: Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode. Arch Gen Psychiatry
2011; 68:791–799
Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH: Subthresold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry
2011; 168:40–48
Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, Sachs GS, Ketter TA: Sleep matters: sleep functioning and course of illness in bipolar disorder. J Affect Disord
2011; 134:416–420
Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, Kieseppä T, Altshuler LL, Fornito A, Malhi GS, McIntosh AM, Yurgelun-Todd DA, Labar KS, Sharma V, MacQueen GM, Murray RM, McDonald C: Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry
2011; 69:326–335
Sachs GS, Dupuy JM, Wittmann CW: The pharmacologic treatment of bipolar disorder. J Clin Psychiatry
2011; 72:704–715
Sidor MM, MacQueen GM: Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry
2011; 72:156–167
Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E, WAVE-bd Study Group: Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry
2011; 11:58
Amsterdam JD, Shults J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry
2010; 167;792–800
BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet
2010; 375:385–395
Ellison-Wright I, Bullmore E: Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res
2010; 117:1–12
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry
2010; 11:81–109
Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW: Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry
2010; 167:1254–1263
Parikh SV, LeBlanc SR, Ovanessian MM: Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Can J Psychiatry
2010; 55:136–143
Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS: Transition to mania during treatment of bipolar depression. Neuropsychopharmacology
2010; 35:2545–2552
Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA: The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry
2010; 71:1488–1501
Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I TRIAL 001 Investigators: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry
2010; 71:150–162
Zimmerman M, Ruggero CJ, Chelminski I, Young D: Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiatry
2010; 71:26–31
Frye MA, Helleman G, Mcelroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T: Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry
2009; 166:164–172
Geddes JR, Calabrese JR, Goodwin GM: Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry
2009; 194:4–9
Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry
2009; 166:173–181
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry
2009; 70:1078–1090
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry
2009; 10:85–116
International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature
2009; 460:748–752
Martinowich K, Schloesser RJ, Manji HK: Bipolar disorder: from genes to behavior pathways. J Clin Invest
2009;119:726–736
Miklowitz DJ, Scott J: Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disord
2009;11(Suppl 2):110–122
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M: The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord
2009; 11:559–595
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord
2009; 11:453–473
Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM Advisory Board: Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). J Affect Disord
2009; 118:118–123
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, Macqueen G, Mcintyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese Jr, Berk M, Ha K, Kapczinski F: Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update. Bipolar Disord
2009; 11:225–255
Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, Holsboer F, Angst J: Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry
2009; 66:1341–1352
Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry
2008; 65:395–407
Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP: Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev
2007; 1:CD004854
Sachs GS: Bipolar disorder clinical synthesis: where does the evidence lead? Focus
2007; 5:3–13